Skip to content
healthcare.dev

Clindamycin Palmitate Hydrochloride

NDC 62135-926, Clindamycin Palmitate Hydrochloride, granule, for solution, from Chartwell RX, LLC.

Product NDC
62135-926
Status
Listed
Labeler
Chartwell RX, LLC
Dosage form
GRANULE, FOR SOLUTION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206958
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62135-926 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CLINDAMYCIN PALMITATE HYDROCHLORIDE75 mg/5mL

Pharmacologic classes

Decreased Sebaceous Gland Activity [PE]; Lincosamide Antibacterial [EPC]; Lincosamides [CS]; Neuromuscular Blockade [PE]

Package NDCNDC-11Package
62135-926-0162135092601100 mL in 1 BOTTLE (62135-926-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5d120b48-8181-4f40-a0e5-1f5cd0450d4f

Use it

Look up 62135-926 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62135-926 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62135-926. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.